1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Cell and Gene Therapy Drug Delivery Devices Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Sterile Insulin Syringe 1.2.3 Pre-Filled Syringe 1.2.4 Infusion Bags 1.3 Market by Application 1.3.1 Global Cell and Gene Therapy Drug Delivery Devices Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Luxturna 1.3.3 Kymriah 1.3.4 Provenge 1.3.5 Zolgensma 1.3.6 Yescarta 1.3.7 Strimvelis 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Cell and Gene Therapy Drug Delivery Devices Market Perspective (2016-2027) 2.2 Cell and Gene Therapy Drug Delivery Devices Growth Trends by Regions 2.2.1 Cell and Gene Therapy Drug Delivery Devices Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Cell and Gene Therapy Drug Delivery Devices Historic Market Share by Regions (2016-2021) 2.2.3 Cell and Gene Therapy Drug Delivery Devices Forecasted Market Size by Regions (2022-2027) 2.3 Cell and Gene Therapy Drug Delivery Devices Industry Dynamic 2.3.1 Cell and Gene Therapy Drug Delivery Devices Market Trends 2.3.2 Cell and Gene Therapy Drug Delivery Devices Market Drivers 2.3.3 Cell and Gene Therapy Drug Delivery Devices Market Challenges 2.3.4 Cell and Gene Therapy Drug Delivery Devices Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Cell and Gene Therapy Drug Delivery Devices Players by Revenue 3.1.1 Global Top Cell and Gene Therapy Drug Delivery Devices Players by Revenue (2016-2021) 3.1.2 Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Players (2016-2021) 3.2 Global Cell and Gene Therapy Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Cell and Gene Therapy Drug Delivery Devices Revenue 3.4 Global Cell and Gene Therapy Drug Delivery Devices Market Concentration Ratio 3.4.1 Global Cell and Gene Therapy Drug Delivery Devices Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Cell and Gene Therapy Drug Delivery Devices Revenue in 2020 3.5 Cell and Gene Therapy Drug Delivery Devices Key Players Head office and Area Served 3.6 Key Players Cell and Gene Therapy Drug Delivery Devices Product Solution and Service 3.7 Date of Enter into Cell and Gene Therapy Drug Delivery Devices Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Cell and Gene Therapy Drug Delivery Devices Breakdown Data by Type 4.1 Global Cell and Gene Therapy Drug Delivery Devices Historic Market Size by Type (2016-2021) 4.2 Global Cell and Gene Therapy Drug Delivery Devices Forecasted Market Size by Type (2022-2027) 5 Cell and Gene Therapy Drug Delivery Devices Breakdown Data by Application 5.1 Global Cell and Gene Therapy Drug Delivery Devices Historic Market Size by Application (2016-2021) 5.2 Global Cell and Gene Therapy Drug Delivery Devices Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Cell and Gene Therapy Drug Delivery Devices Market Size (2016-2027) 6.2 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Type 6.2.1 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2016-2021) 6.2.2 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2022-2027) 6.2.3 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2016-2027) 6.3 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Application 6.3.1 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2016-2021) 6.3.2 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2022-2027) 6.3.3 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2016-2027) 6.4 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Country 6.4.1 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2016-2021) 6.4.2 North America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Cell and Gene Therapy Drug Delivery Devices Market Size (2016-2027) 7.2 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Type 7.2.1 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2016-2021) 7.2.2 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2022-2027) 7.2.3 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2016-2027) 7.3 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Application 7.3.1 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2016-2021) 7.3.2 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2022-2027) 7.3.3 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2016-2027) 7.4 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Country 7.4.1 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2016-2021) 7.4.2 Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size (2016-2027) 8.2 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Type 8.2.1 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2016-2027) 8.3 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Application 8.3.1 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2016-2027) 8.4 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Region 8.4.1 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size (2016-2027) 9.2 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Type 9.2.1 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2016-2021) 9.2.2 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2022-2027) 9.2.3 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2016-2027) 9.3 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Application 9.3.1 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2016-2021) 9.3.2 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2022-2027) 9.3.3 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2016-2027) 9.4 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Country 9.4.1 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2016-2021) 9.4.2 Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size (2016-2027) 10.2 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Type 10.2.1 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2016-2027) 10.3 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Application 10.3.1 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2016-2027) 10.4 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Country 10.4.1 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Amgen, Inc. 11.1.1 Amgen, Inc. Company Details 11.1.2 Amgen, Inc. Business Overview 11.1.3 Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Introduction 11.1.4 Amgen, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021) 11.1.5 Amgen, Inc. Recent Development 11.2 Bausch and Lomb Incorporated 11.2.1 Bausch and Lomb Incorporated Company Details 11.2.2 Bausch and Lomb Incorporated Business Overview 11.2.3 Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Introduction 11.2.4 Bausch and Lomb Incorporated Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021) 11.2.5 Bausch and Lomb Incorporated Recent Development 11.3 Becton, Dickinson and Company 11.3.1 Becton, Dickinson and Company Company Details 11.3.2 Becton, Dickinson and Company Business Overview 11.3.3 Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Introduction 11.3.4 Becton, Dickinson and Company Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021) 11.3.5 Becton, Dickinson and Company Recent Development 11.4 Bluebird bio, Inc. 11.4.1 Bluebird bio, Inc. Company Details 11.4.2 Bluebird bio, Inc. Business Overview 11.4.3 Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Introduction 11.4.4 Bluebird bio, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021) 11.4.5 Bluebird bio, Inc. Recent Development 11.5 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) 11.5.1 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Company Details 11.5.2 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Business Overview 11.5.3 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Introduction 11.5.4 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021) 11.5.5 Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Recent Development 11.6 Dendreon Pharmaceuticals LLC. 11.6.1 Dendreon Pharmaceuticals LLC. Company Details 11.6.2 Dendreon Pharmaceuticals LLC. Business Overview 11.6.3 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Introduction 11.6.4 Dendreon Pharmaceuticals LLC. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021) 11.6.5 Dendreon Pharmaceuticals LLC. Recent Development 11.7 Helixmith Co., Ltd (ViroMed Co., Ltd) 11.7.1 Helixmith Co., Ltd (ViroMed Co., Ltd) Company Details 11.7.2 Helixmith Co., Ltd (ViroMed Co., Ltd) Business Overview 11.7.3 Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Introduction 11.7.4 Helixmith Co., Ltd (ViroMed Co., Ltd) Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021) 11.7.5 Helixmith Co., Ltd (ViroMed Co., Ltd) Recent Development 11.8 Human Stem Cell Institute 11.8.1 Human Stem Cell Institute Company Details 11.8.2 Human Stem Cell Institute Business Overview 11.8.3 Human Stem Cell Institute Cell and Gene Therapy Drug Delivery Devices Introduction 11.8.4 Human Stem Cell Institute Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021) 11.8.5 Human Stem Cell Institute Recent Development 11.9 Kite Pharma, Inc. 11.9.1 Kite Pharma, Inc. Company Details 11.9.2 Kite Pharma, Inc. Business Overview 11.9.3 Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Introduction 11.9.4 Kite Pharma, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021) 11.9.5 Kite Pharma, Inc. Recent Development 11.10 Kolon Tissue Gene, inc. 11.10.1 Kolon Tissue Gene, inc. Company Details 11.10.2 Kolon Tissue Gene, inc. Business Overview 11.10.3 Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Introduction 11.10.4 Kolon Tissue Gene, inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021) 11.10.5 Kolon Tissue Gene, inc. Recent Development 11.11 Novartis AG 11.11.1 Novartis AG Company Details 11.11.2 Novartis AG Business Overview 11.11.3 Novartis AG Cell and Gene Therapy Drug Delivery Devices Introduction 11.11.4 Novartis AG Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021) 11.11.5 Novartis AG Recent Development 11.12 Orchard Therapeutics plc. 11.12.1 Orchard Therapeutics plc. Company Details 11.12.2 Orchard Therapeutics plc. Business Overview 11.12.3 Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Introduction 11.12.4 Orchard Therapeutics plc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021) 11.12.5 Orchard Therapeutics plc. Recent Development 11.13 Pfizer, Inc. 11.13.1 Pfizer, Inc. Company Details 11.13.2 Pfizer, Inc. Business Overview 11.13.3 Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Introduction 11.13.4 Pfizer, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021) 11.13.5 Pfizer, Inc. Recent Development 11.14 Renova Therapeutics 11.14.1 Renova Therapeutics Company Details 11.14.2 Renova Therapeutics Business Overview 11.14.3 Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Introduction 11.14.4 Renova Therapeutics Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021) 11.14.5 Renova Therapeutics Recent Development 11.15 Spark Therapeutics, Inc. 11.15.1 Spark Therapeutics, Inc. Company Details 11.15.2 Spark Therapeutics, Inc. Business Overview 11.15.3 Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Introduction 11.15.4 Spark Therapeutics, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021) 11.15.5 Spark Therapeutics, Inc. Recent Development 11.16 uniQure N.V. 11.16.1 uniQure N.V. Company Details 11.16.2 uniQure N.V. Business Overview 11.16.3 uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Introduction 11.16.4 uniQure N.V. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021) 11.16.5 uniQure N.V. Recent Development 11.17 Vericel Corporation 11.17.1 Vericel Corporation Company Details 11.17.2 Vericel Corporation Business Overview 11.17.3 Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Introduction 11.17.4 Vericel Corporation Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021) 11.17.5 Vericel Corporation Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Cell and Gene Therapy Drug Delivery Devices Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Sterile Insulin Syringe Table 3. Key Players of Pre-Filled Syringe Table 4. Key Players of Infusion Bags Table 5. Global Cell and Gene Therapy Drug Delivery Devices Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Cell and Gene Therapy Drug Delivery Devices Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Cell and Gene Therapy Drug Delivery Devices Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global Cell and Gene Therapy Drug Delivery Devices Market Share by Regions (2016-2021) Table 9. Global Cell and Gene Therapy Drug Delivery Devices Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global Cell and Gene Therapy Drug Delivery Devices Market Share by Regions (2022-2027) Table 11. Cell and Gene Therapy Drug Delivery Devices Market Trends Table 12. Cell and Gene Therapy Drug Delivery Devices Market Drivers Table 13. Cell and Gene Therapy Drug Delivery Devices Market Challenges Table 14. Cell and Gene Therapy Drug Delivery Devices Market Restraints Table 15. Global Cell and Gene Therapy Drug Delivery Devices Revenue by Players (2016-2021) & (US$ Million) Table 16. Global Cell and Gene Therapy Drug Delivery Devices Market Share by Players (2016-2021) Table 17. Global Top Cell and Gene Therapy Drug Delivery Devices Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cell and Gene Therapy Drug Delivery Devices as of 2020) Table 18. Ranking of Global Top Cell and Gene Therapy Drug Delivery Devices Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by Cell and Gene Therapy Drug Delivery Devices Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Cell and Gene Therapy Drug Delivery Devices Product Solution and Service Table 22. Date of Enter into Cell and Gene Therapy Drug Delivery Devices Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2016-2021) (US$ Million) Table 25. Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Type (2016-2021) Table 26. Global Cell and Gene Therapy Drug Delivery Devices Forecasted Market Size by Type (2022-2027) (US$ Million) Table 27. Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Type (2022-2027) & (US$ Million) Table 28. Global Cell and Gene Therapy Drug Delivery Devices Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Application (2016-2021) Table 30. Global Cell and Gene Therapy Drug Delivery Devices Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2016-2021) (US$ Million) Table 33. North America Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2022-2027) & (US$ Million) Table 34. North America Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2016-2021) (US$ Million) Table 35. North America Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2022-2027) & (US$ Million) Table 36. North America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2016-2021) & (US$ Million) Table 37. North America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2016-2021) (US$ Million) Table 39. Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2022-2027) & (US$ Million) Table 40. Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2016-2021) (US$ Million) Table 41. Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2016-2021) (US$ Million) Table 45. Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2022-2027) & (US$ Million) Table 46. Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2016-2021) (US$ Million) Table 51. Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2022-2027) & (US$ Million) Table 52. Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2016-2021) (US$ Million) Table 57. Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Type (2022-2027) & (US$ Million) Table 58. Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2016-2021) (US$ Million) Table 59. Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Application (2022-2027) & (US$ Million) Table 60. Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size by Country (2022-2027) & (US$ Million) Table 62. Amgen, Inc. Company Details Table 63. Amgen, Inc. Business Overview Table 64. Amgen, Inc. Cell and Gene Therapy Drug Delivery Devices Product Table 65. Amgen, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021) & (US$ Million) Table 66. Amgen, Inc. Recent Development Table 67. Bausch and Lomb Incorporated Company Details Table 68. Bausch and Lomb Incorporated Business Overview Table 69. Bausch and Lomb Incorporated Cell and Gene Therapy Drug Delivery Devices Product Table 70. Bausch and Lomb Incorporated Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021) & (US$ Million) Table 71. Bausch and Lomb Incorporated Recent Development Table 72. Becton, Dickinson and Company Company Details Table 73. Becton, Dickinson and Company Business Overview Table 74. Becton, Dickinson and Company Cell and Gene Therapy Drug Delivery Devices Product Table 75. Becton, Dickinson and Company Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021) & (US$ Million) Table 76. Becton, Dickinson and Company Recent Development Table 77. Bluebird bio, Inc. Company Details Table 78. Bluebird bio, Inc. Business Overview Table 79. Bluebird bio, Inc. Cell and Gene Therapy Drug Delivery Devices Product Table 80. Bluebird bio, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021) & (US$ Million) Table 81. Bluebird bio, Inc. Recent Development Table 82. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Company Details Table 83. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Business Overview Table 84. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Cell and Gene Therapy Drug Delivery Devices Product Table 85. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021) & (US$ Million) Table 86. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Recent Development Table 87. Dendreon Pharmaceuticals LLC. Company Details Table 88. Dendreon Pharmaceuticals LLC. Business Overview Table 89. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Drug Delivery Devices Product Table 90. Dendreon Pharmaceuticals LLC. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021) & (US$ Million) Table 91. Dendreon Pharmaceuticals LLC. Recent Development Table 92. Helixmith Co., Ltd (ViroMed Co., Ltd) Company Details Table 93. Helixmith Co., Ltd (ViroMed Co., Ltd) Business Overview Table 94. Helixmith Co., Ltd (ViroMed Co., Ltd) Cell and Gene Therapy Drug Delivery Devices Product Table 95. Helixmith Co., Ltd (ViroMed Co., Ltd) Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021) & (US$ Million) Table 96. Helixmith Co., Ltd (ViroMed Co., Ltd) Recent Development Table 97. Human Stem Cell Institute Company Details Table 98. Human Stem Cell Institute Business Overview Table 99. Human Stem Cell Institute Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021) & (US$ Million) Table 100. Human Stem Cell Institute Recent Development Table 101. Kite Pharma, Inc. Company Details Table 102. Kite Pharma, Inc. Business Overview Table 103. Kite Pharma, Inc. Cell and Gene Therapy Drug Delivery Devices Product Table 104. Kite Pharma, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021) & (US$ Million) Table 105. Kite Pharma, Inc. Recent Development Table 106. Kolon Tissue Gene, inc. Company Details Table 107. Kolon Tissue Gene, inc. Business Overview Table 108. Kolon Tissue Gene, inc. Cell and Gene Therapy Drug Delivery Devices Product Table 109. Kolon Tissue Gene, inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021) & (US$ Million) Table 110. Kolon Tissue Gene, inc. Recent Development Table 111. Novartis AG Company Details Table 112. Novartis AG Business Overview Table 113. Novartis AG Cell and Gene Therapy Drug Delivery Devices Product Table 114. Novartis AG Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021) & (US$ Million) Table 115. Novartis AG Recent Development Table 116. Orchard Therapeutics plc. Company Details Table 117. Orchard Therapeutics plc. Business Overview Table 118. Orchard Therapeutics plc. Cell and Gene Therapy Drug Delivery Devices Product Table 119. Orchard Therapeutics plc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021) & (US$ Million) Table 120. Orchard Therapeutics plc. Recent Development Table 121. Pfizer, Inc. Company Details Table 122. Pfizer, Inc. Business Overview Table 123. Pfizer, Inc. Cell and Gene Therapy Drug Delivery Devices Product Table 124. Pfizer, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021) & (US$ Million) Table 125. Pfizer, Inc. Recent Development Table 126. Renova Therapeutics Company Details Table 127. Renova Therapeutics Business Overview Table 128. Renova Therapeutics Cell and Gene Therapy Drug Delivery Devices Product Table 129. Renova Therapeutics Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021) & (US$ Million) Table 130. Renova Therapeutics Recent Development Table 131. Spark Therapeutics, Inc. Company Details Table 132. Spark Therapeutics, Inc. Business Overview Table 133. Spark Therapeutics, Inc. Cell and Gene Therapy Drug Delivery Devices Product Table 134. Spark Therapeutics, Inc. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021) & (US$ Million) Table 135. Spark Therapeutics, Inc. Recent Development Table 136. uniQure N.V. Company Details Table 137. uniQure N.V. Business Overview Table 138. uniQure N.V. Cell and Gene Therapy Drug Delivery Devices Product Table 139. uniQure N.V. Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021) & (US$ Million) Table 140. uniQure N.V. Recent Development Table 141. Vericel Corporation Company Details Table 142. Vericel Corporation Business Overview Table 143. Vericel Corporation Cell and Gene Therapy Drug Delivery Devices Product Table 144. Vericel Corporation Revenue in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021) & (US$ Million) Table 145. Vericel Corporation Recent Development Table 146. Research Programs/Design for This Report Table 147. Key Data Information from Secondary Sources Table 148. Key Data Information from Primary Sources List of Figures Figure 1. Global Cell and Gene Therapy Drug Delivery Devices Market Share by Type: 2020 VS 2027 Figure 2. Sterile Insulin Syringe Features Figure 3. Pre-Filled Syringe Features Figure 4. Infusion Bags Features Figure 5. Global Cell and Gene Therapy Drug Delivery Devices Market Share by Application: 2020 VS 2027 Figure 6. Luxturna Case Studies Figure 7. Kymriah Case Studies Figure 8. Provenge Case Studies Figure 9. Zolgensma Case Studies Figure 10. Yescarta Case Studies Figure 11. Strimvelis Case Studies Figure 12. Cell and Gene Therapy Drug Delivery Devices Report Years Considered Figure 13. Global Cell and Gene Therapy Drug Delivery Devices Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 14. Global Cell and Gene Therapy Drug Delivery Devices Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 15. Global Cell and Gene Therapy Drug Delivery Devices Market Share by Regions: 2020 VS 2027 Figure 16. Global Cell and Gene Therapy Drug Delivery Devices Market Share by Regions (2022-2027) Figure 17. Global Cell and Gene Therapy Drug Delivery Devices Market Share by Players in 2020 Figure 18. Global Top Cell and Gene Therapy Drug Delivery Devices Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cell and Gene Therapy Drug Delivery Devices as of 2020 Figure 19. The Top 10 and 5 Players Market Share by Cell and Gene Therapy Drug Delivery Devices Revenue in 2020 Figure 20. Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Type (2016-2021) Figure 21. Global Cell and Gene Therapy Drug Delivery Devices Revenue Market Share by Type (2022-2027) Figure 22. North America Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. North America Cell and Gene Therapy Drug Delivery Devices Market Share by Type (2016-2027) Figure 24. North America Cell and Gene Therapy Drug Delivery Devices Market Share by Application (2016-2027) Figure 25. North America Cell and Gene Therapy Drug Delivery Devices Market Share by Country (2016-2027) Figure 26. United States Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Canada Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Europe Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. Europe Cell and Gene Therapy Drug Delivery Devices Market Share by Type (2016-2027) Figure 30. Europe Cell and Gene Therapy Drug Delivery Devices Market Share by Application (2016-2027) Figure 31. Europe Cell and Gene Therapy Drug Delivery Devices Market Share by Country (2016-2027) Figure 32. Germany Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. France Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. U.K. Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Italy Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Russia Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Nordic Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Share by Type (2016-2027) Figure 40. Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Share by Application (2016-2027) Figure 41. Asia-Pacific Cell and Gene Therapy Drug Delivery Devices Market Share by Region (2016-2027) Figure 42. China Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Japan Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. South Korea Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Southeast Asia Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. India Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Australia Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Latin America Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Latin America Cell and Gene Therapy Drug Delivery Devices Market Share by Type (2016-2027) Figure 50. Latin America Cell and Gene Therapy Drug Delivery Devices Market Share by Application (2016-2027) Figure 51. Latin America Cell and Gene Therapy Drug Delivery Devices Market Share by Country (2016-2027) Figure 52. Mexico Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Brazil Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Share by Type (2016-2027) Figure 56. Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Share by Application (2016-2027) Figure 57. Middle East & Africa Cell and Gene Therapy Drug Delivery Devices Market Share by Country (2016-2027) Figure 58. Turkey Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Saudi Arabia Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. UAE Cell and Gene Therapy Drug Delivery Devices Market Size YoY Growth (2016-2027) & (US$ Million) Figure 61. Amgen, Inc. Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021) Figure 62. Bausch and Lomb Incorporated Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021) Figure 63. Becton, Dickinson and Company Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021) Figure 64. Bluebird bio, Inc. Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021) Figure 65. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021) Figure 66. Dendreon Pharmaceuticals LLC. Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021) Figure 67. Helixmith Co., Ltd (ViroMed Co., Ltd) Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021) Figure 68. Human Stem Cell Institute Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021) Figure 69. Kite Pharma, Inc. Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021) Figure 70. Kolon Tissue Gene, inc. Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021) Figure 71. Novartis AG Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021) Figure 72. Orchard Therapeutics plc. Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021) Figure 73. Pfizer, Inc. Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021) Figure 74. Renova Therapeutics Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021) Figure 75. Spark Therapeutics, Inc. Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021) Figure 76. uniQure N.V. Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021) Figure 77. Vericel Corporation Revenue Growth Rate in Cell and Gene Therapy Drug Delivery Devices Business (2016-2021) Figure 78. Bottom-up and Top-down Approaches for This Report Figure 79. Data Triangulation Figure 80. Key Executives Interviewed

Amgen, Inc. Bausch and Lomb Incorporated Becton, Dickinson and Company Bluebird bio, Inc. Castle Creek Biosciences, Inc (Fibrocell Technologies, Inc.) Dendreon Pharmaceuticals LLC. Helixmith Co., Ltd (ViroMed Co., Ltd) Human Stem Cell Institute Kite Pharma, Inc. Kolon Tissue Gene, inc. Novartis AG Orchard Therapeutics plc. Pfizer, Inc. Renova Therapeutics Spark Therapeutics, Inc. uniQure N.V. Vericel Corporation